Piper Sandler Initiates Coverage On LeonaBio with Overweight Rating, Announces Price Target of $20

Benzinga Newsdesk www.benzinga.com Neutral 60.7%

Neg 0% Neu 60.7% Pos 0%

Piper Sandler analyst Kelsey Goodwin initiates coverage on LeonaBio (NASDAQ:LONA) with a Overweight rating and announces Price Target of $20.